This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 1992 Sep;14(1):1-3.

doi: 10.1002/ppul.1950140102.

On exogenous surfactant therapy

T A Merritt, H L Halliday

PMID: 1437336
DOI: 10.1002/ppul.1950140102

Editorial

On exogenous surfactant therapy

T A Merritt et al. Pediatr Pulmonol. 1992 Sep.

. 1992 Sep;14(1):1-3.

doi: 10.1002/ppul.1950140102.

Authors

T A Merritt, H L Halliday

PMID: 1437336
DOI: 10.1002/ppul.1950140102

Erratum in

Pediatr Pulmonol 1992 Nov;14(3):199

No abstract available

PubMed Disclaimer

Comment in

On exogenous surfactant therapy.
Gortner L. Gortner L. Pediatr Pulmonol. 1993 Feb;15(2):128-9. doi: 10.1002/ppul.1950150212. Pediatr Pulmonol. 1993. PMID: 8474786 No abstract available.

Comment on

Lung mechanics and gas exchange in ventilated preterm infants during treatment of hyaline membrane disease with multiple doses of artificial surfactant (Exosurf).
Pfenninger J, Aebi C, Bachmann D, Wagner BP. Pfenninger J, et al. Pediatr Pulmonol. 1992 Sep;14(1):10-5. doi: 10.1002/ppul.1950140104. Pediatr Pulmonol. 1992. PMID: 1437337
Early treatment of respiratory distress syndrome with bovine surfactant in very preterm infants: a multicenter controlled clinical trial.
Gortner L, Bartmann P, Pohlandt F, Bernsau U, Porz F, Hellwege HH, Seitz RC, Hieronimi G, Bremer C, Jorch G, et al. Gortner L, et al. Pediatr Pulmonol. 1992 Sep;14(1):4-9. doi: 10.1002/ppul.1950140103. Pediatr Pulmonol. 1992. PMID: 1437342 Clinical Trial.

Similar articles

Surfactant phospholipids and surface activity among preterm infants with respiratory distress syndrome who develop bronchopulmonary dysplasia.
Kazzi SN, Schürch S, McLaughlin KL, Romero R, Janisse J. Kazzi SN, et al. Acta Paediatr. 2000 Oct;89(10):1218-25. doi: 10.1080/080352500750027600. Acta Paediatr. 2000. PMID: 11083379
Minimally Invasive Surfactant Therapy vs Sham Treatment and Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome.
Razak A. Razak A. JAMA. 2022 Apr 26;327(16):1613. doi: 10.1001/jama.2022.2923. JAMA. 2022. PMID: 35471524 No abstract available.
Minimally Invasive Surfactant Therapy vs Sham Treatment and Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome.
Zhou P, Han T. Zhou P, et al. JAMA. 2022 Apr 26;327(16):1613-1614. doi: 10.1001/jama.2022.2926. JAMA. 2022. PMID: 35471523 No abstract available.
[Secondary surfactant deficiencies].
Escande B, Kuhn P, Rivera S, Messer J. Escande B, et al. Arch Pediatr. 2004 Nov;11(11):1351-9. doi: 10.1016/j.arcped.2004.05.021. Arch Pediatr. 2004. PMID: 15519836 Review. French.
Porcine-derived lung surfactant. A review of the therapeutic efficacy and clinical tolerability of a natural surfactant preparation (Curosurf) in neonatal respiratory distress syndrome.
Wiseman LR, Bryson HM. Wiseman LR, et al. Drugs. 1994 Sep;48(3):386-403. doi: 10.2165/00003495-199448030-00006. Drugs. 1994. PMID: 7527760 Review.

See all similar articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Wiley
Other Literature Sources
- The Lens - Patent Citations Database